- AP published this report on yesterday’s House hearing on "reverse payment" settlements.
- AP also recently published this article on follow-on biologics legislation, entitled "Time is Running Out for Generic Biotech."
- Antitrust Review recently posted an update on the FTC’s authorized generics study.
- FDA Law Blog has a new post today on the most recent developments in the generic Norvasc litigation.
- FDA Law Blog also posted last week on a Medicis challenge to FDA’s policy regarding exclusivity for "old" antibiotics.
- Patent Docs has two interesting recent posts–here and here–on applying TRIPS to patented drugs in developing countries.
- Patently-O has a new post today by Cal Crary, a pharma litigation analyst: "Impact of KSR v. Teleflex on the Pharmaceutical Industry."
- PhRMA put out this press release on the U.S. Trade Representative’s annual report on IP rights; see also this related post on Pharmalot.
- Pharmalot also recently had this interesting post on India’s generic drug companies.
Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Orange Book Blog 
Leave a comment